The cardiac restoration systems market involves devices that are implanted surgically to treat heart failure. These include annuloplasty rings or bands, ventricular partitioning devices, and mitral valves. Cardiac restoration devices reshape the heart and reduce the volume of the heart's ventricles, improving its pumping efficiency. The implantation of these devices is a minimally invasive procedure performed through small incisions rather than open-chest surgery. They help improve heart function and symptoms in patients with heart failure by reducing the size of the enlarged ventricle and restricting the heart muscles from further stretching.
The cardiac restoration systems market is estimated to be valued at USD 2.63 Billion in 2024 and is expected to reach USD 3.75 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Key players operating in the cardiac restoration systems market are Abbott Laboratories, BioVentrix, CryoLife Inc., Edwards Lifesciences Corporation, NeoChord Inc.
Growing Demand: The increasing prevalence of heart failure, cardiomyopathy, and coronary artery disease is driving the demand for cardiac restoration systems. As per estimates, over 26 million people globally suffer from heart failure.
Technological Advancements: New technologies such as robotic catheter-based device delivery systems and artificial intelligence-enabled postoperative monitoring devices are being developed. Transcatheter approaches have gained popularity as they avoid open-heart surgery.
Market Trends
Increasing Adoption of Minimally Invasive Procedures: The Cardiac Restoration Systems Market is witnessing increased adoption of minimally invasive surgical procedures such as catheter ablation and robotic surgery. They are associated with less pain, scarring, and faster recovery time compared to conventional open-chest surgery.
Rise of Telehealth and Digital Health Solutions: The vendors are offering digital health solutions that enable remote patient monitoring and collecting physiological data before and after surgery using mobile apps, smartwatches, and Bluetooth devices. This helps optimize treatments.
Market Opportunities
Emerging Countries: Growing healthcare expenditure and increasing focus on cardiac care in emerging nations such as India, China, Brazil provide large opportunities.
Combination Therapy: Companies are developing combination therapies involving cardiac restoration devices along with cardiomyoplasty (grafting material onto the heart) or gene therapies for better outcomes. This will expand treatment options.
How COVID-19 has impacted the growth of Cardiac Restoration Systems Market:
The outbreak of the COVID-19 pandemic has adversely impacted the growth of the cardiac restoration systems market. In the initial months of the pandemic, elective procedures like cardiac restoration procedures were postponed to avoid virus transmission and focus more on handling critically ill COVID-19 patients. This led to a steep decline in the demand for cardiac restoration systems in 2020. However, as the restrictions are being gradually lifted globally with an increased availability of vaccines, the deferral of elective cardiac procedures is being addressed. This is enabling the restoration of demand levels for cardiac restoration systems.
Nevertheless, complete recovery of market growth to the pre-pandemic levels is likely to take more time. The lingering fears of virus exposure and economic stresses continue to discourage some patients from opting for non-critical cardiac procedures. The manufacturers also faced disruptions in their supply chains and production activities during the peak pandemic period. Going forward, new device launches and innovations in minimally invasive techniques are expected to boost the market again. However, the industry players would need to focus on gaining back lost confidence and addressing ongoing concerns regarding procedure safety to aid full market recovery.
Geographical Regions with highest Cardiac Restoration Systems Market value:
The United States represents the largest regional market for cardiac restoration systems in terms of value. This is attributed to the high incidence of heart failure cases and adoption of advanced cardiac interventions in the country. As per the American Heart Association's estimates, over 5.7 million American adults suffer from heart failure currently. This high prevalence drives significant procedural volumes and sales of cardiac restoration systems in the nation. Europe also holds a substantial share in the global market, led by the presence of major medical device companies and availability of favorable reimbursement schemes for cardiac procedures across different countries.
Fastest growing regional market for Cardiac Restoration Systems:
The Asia Pacific region is projected to witness the highest growth in the cardiac restoration systems market over the coming years. This is owing to factors like rising cardiovascular disease (CVD) burden associated with rapid economic growth, increasing healthcare expenditures, growing medical tourism, and improving access to advanced cardiac therapies. In particular, developing countries like China and India are expected to be the hotspots for future market growth due to their huge patient populations and rising healthcare standards. Meanwhile, increasing collaborations between Asia Pacific players and global market leaders are also enhancing the availability of innovative cardiac restoration technologies in the region, thus supplementing market expansion.
Get more insights on - Cardiac Restoration Systems Market
Get this Report in Japanese Language: 心臓修復システム市場
Get this Report in Korean Language: 심장 복원 시스템 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
